Target Delivery of Anti-tumour Therapeutics for Improved Cancer Treatment
Duration:
January 2020–July 2025
Project Summary
This project uses the CaP-lipid-based nanoparticle to deliver therapeutic agents (such as siRNAs, growth factors, cytokines, and/or drugs) to target cells, tumours or tumour microenvironment, leading to the regression or even the elimination of solid tumours.
![](/files/8706/Xugroupproject2.jpg)
Research Group
Keywords
Nanomaterials, Nanobiotechnology, Health, Target delivery, Tumour, Nanoparticle, Tumor Microenvironment, RNAi, Cytokines, Anti-tumour Therapeutics
Available Student Projects
CaP nanoparticle-based encapsulated system for target drug delivery